Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Haanen

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1990
Mycobacterium leprae-specific T cells from a tuberculoid leprosy patient suppress HLA-DR3-restricted T cell responses to an immunodominant epitope on 65-kDa hsp of mycobacteriaJ B Haanen, T H Ottenhoff, R F Lai A Fat, et al.
Gene Therapy|March 11, 2015
Antigen design enhances the immunogenicity of Semliki Forest virus-based therapeutic human papillomavirus vaccinesP P Ip, A Boerma, M Walczak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1993
Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patientsT Mutis, E M Kraakman, Y E Cornelisse, et al.
Scandinavian Journal of Immunology|January 1, 1986
HLA class-II-restricted Mycobacterium leprae-reactive T-cell clones from leprosy patients established with a minimal requirement for autologous mononuclear cellsJ B Haanen, T H Ottenhoff, A Voordouw, et al.
European Journal of Immunology|May 23, 2000
Tumor size at the time of adoptive transfer determines whether tumor rejection occursT A Cordaro, K E de Visser, F H Tirion, et al.
The Journal of Experimental Medicine|September 1, 1991
Selection of a human T helper type 1-like T cell subset by mycobacteriaJ B Haanen, R de Waal Malefijt, P C Res, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1992
T-cell receptor beta-chain gene usage in the T-cell recognition of Mycobacterium leprae antigens in one tuberculoid leprosy patientW C van Schooten, J L Ko, N van der Stoep, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
A redundant role of the CD3 gamma-immunoreceptor tyrosine-based activation motif in mature T cell functionM C Haks, T A Cordaro, J H van den Brakel, et al.
Clinical Pharmacology and Therapeutics|September 6, 2012
Polymorphisms in endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor (VEGF) predict sunitinib-induced hypertensionK Eechoute, A A M van der Veldt, S Oosting, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 studyP B Chapman, C Robert, J Larkin, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1990
Mycobacterium leprae-specific T cells from a tuberculoid leprosy patient suppress HLA-DR3-restricted T cell responses to an immunodominant epitope on 65-kDa hsp of mycobacteriaJ B Haanen, T H Ottenhoff, R F Lai A Fat, et al.
Gene Therapy|March 11, 2015
Antigen design enhances the immunogenicity of Semliki Forest virus-based therapeutic human papillomavirus vaccinesP P Ip, A Boerma, M Walczak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1993
Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patientsT Mutis, E M Kraakman, Y E Cornelisse, et al.
Scandinavian Journal of Immunology|January 1, 1986
HLA class-II-restricted Mycobacterium leprae-reactive T-cell clones from leprosy patients established with a minimal requirement for autologous mononuclear cellsJ B Haanen, T H Ottenhoff, A Voordouw, et al.
European Journal of Immunology|May 23, 2000
Tumor size at the time of adoptive transfer determines whether tumor rejection occursT A Cordaro, K E de Visser, F H Tirion, et al.
The Journal of Experimental Medicine|September 1, 1991
Selection of a human T helper type 1-like T cell subset by mycobacteriaJ B Haanen, R de Waal Malefijt, P C Res, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1992
T-cell receptor beta-chain gene usage in the T-cell recognition of Mycobacterium leprae antigens in one tuberculoid leprosy patientW C van Schooten, J L Ko, N van der Stoep, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
A redundant role of the CD3 gamma-immunoreceptor tyrosine-based activation motif in mature T cell functionM C Haks, T A Cordaro, J H van den Brakel, et al.
Clinical Pharmacology and Therapeutics|September 6, 2012
Polymorphisms in endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor (VEGF) predict sunitinib-induced hypertensionK Eechoute, A A M van der Veldt, S Oosting, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 studyP B Chapman, C Robert, J Larkin, et al.
Pageof 3